laudanosine has been researched along with Chronic Kidney Failure in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (66.67) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Canfell, C; Castagnoli, K; Fahey, MR; Fisher, DM; Hennis, PJ; Miller, RD; Rupp, SM; Sharma, M | 2 |
| Boyd, AH; Eastwood, NB; Hunter, JM; Parker, CJ | 2 |
| Boheimer, N; Dopson, TA; Simmonds, RJ; Ward, S; Weatherley, BC | 1 |
| Ward, S; Weatherley, BC | 1 |
6 other study(ies) available for laudanosine and Chronic Kidney Failure
| Article | Year |
|---|---|
The pharmacokinetics and pharmacodynamics of atracurium in patients with and without renal failure.
Topics: Anesthesia, General; Atracurium; Chromatography, Ion Exchange; Humans; Isoquinolines; Kidney Failure, Chronic; Kinetics; Models, Biological; Muscle Contraction; Neuromuscular Nondepolarizing Agents | 1984 |
Pharmacokinetics of 1R-cis 1'R-cis atracurium besylate (51W89) and plasma laudanosine concentrations in health and chronic renal failure.
Topics: Adult; Age Factors; Atracurium; Chromatography, High Pressure Liquid; Female; Half-Life; Humans; Isoquinolines; Kidney Failure, Chronic; Male; Middle Aged; Models, Biological; Neuromuscular Nondepolarizing Agents; Sex Factors; Stereoisomerism | 1995 |
Pharmacokinetics of 51W89: preliminary data.
Topics: Atracurium; Half-Life; Humans; Isomerism; Isoquinolines; Kidney; Kidney Failure, Chronic; Metabolic Clearance Rate; Neuromuscular Nondepolarizing Agents; Opium; Renal Dialysis | 1995 |
Pharmacokinetics of atracurium and its metabolites in patients with normal renal function, and in patients in renal failure.
Topics: Adult; Aged; Alcohols; Atracurium; Female; Half-Life; Humans; Isoquinolines; Kidney Failure, Chronic; Kinetics; Male; Mathematics; Middle Aged; Models, Biological | 1987 |
Pharmacokinetics of atracurium and its metabolites.
Topics: Atracurium; Chronic Disease; Half-Life; Humans; Isoquinolines; Kidney Failure, Chronic; Kinetics; Liver Diseases; Metabolic Clearance Rate; Neuromuscular Blocking Agents | 1986 |
Effect of renal failure on laudanosine excretion in man.
Topics: Atracurium; Humans; Isoquinolines; Kidney Failure, Chronic; Neuromuscular Blocking Agents; Time Factors | 1985 |